GB9127252D0 - Therapeutic agents - Google Patents

Therapeutic agents

Info

Publication number
GB9127252D0
GB9127252D0 GB919127252A GB9127252A GB9127252D0 GB 9127252 D0 GB9127252 D0 GB 9127252D0 GB 919127252 A GB919127252 A GB 919127252A GB 9127252 A GB9127252 A GB 9127252A GB 9127252 D0 GB9127252 D0 GB 9127252D0
Authority
GB
United Kingdom
Prior art keywords
alkyl
represents hydrogen
halo
alkoxy
pct
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB919127252A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boots Co PLC
Original Assignee
Boots Co PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co PLC filed Critical Boots Co PLC
Priority to GB919127252A priority Critical patent/GB9127252D0/en
Publication of GB9127252D0 publication Critical patent/GB9127252D0/en
Priority to US08/244,369 priority patent/US5464781A/en
Priority to AT93900052T priority patent/ATE171452T1/de
Priority to HU9401877A priority patent/HUT66971A/hu
Priority to PCT/EP1992/002901 priority patent/WO1993013097A1/en
Priority to CZ941535A priority patent/CZ153594A3/cs
Priority to CA002125858A priority patent/CA2125858A1/en
Priority to RU94030471/04A priority patent/RU94030471A/ru
Priority to JP5511397A priority patent/JP2527917B2/ja
Priority to EP93900052A priority patent/EP0618916B1/en
Priority to SK750-94A priority patent/SK75094A3/sk
Priority to NZ246156A priority patent/NZ246156A/en
Priority to DE69227125T priority patent/DE69227125T2/de
Priority to AU31587/93A priority patent/AU656832B2/en
Priority to IN758MA1992 priority patent/IN174405B/en
Priority to IL104169A priority patent/IL104169A0/xx
Priority to ZA929916A priority patent/ZA929916B/xx
Priority to MX9207494A priority patent/MX9207494A/es
Priority to HR921455A priority patent/HRP921455A2/hr
Priority to SI19929200408A priority patent/SI9200408A/sl
Priority to YU110792A priority patent/YU110792A/sh
Priority to CN93109454A priority patent/CN1096784A/zh
Priority to BG98813A priority patent/BG98813A/bg
Priority to FI943019A priority patent/FI943019A0/fi
Priority to NO942376A priority patent/NO942376L/no
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GB919127252A 1991-12-23 1991-12-23 Therapeutic agents Pending GB9127252D0 (en)

Priority Applications (25)

Application Number Priority Date Filing Date Title
GB919127252A GB9127252D0 (en) 1991-12-23 1991-12-23 Therapeutic agents
US08/244,369 US5464781A (en) 1991-12-23 1992-10-12 Amino naphthyridine compounds as anti-rhoumatic agents
HU9401877A HUT66971A (en) 1991-12-23 1992-12-12 4-amino-naphthyridine derivatives pharmaceutical compositions containing the same and process for the production of thereof
DE69227125T DE69227125T2 (de) 1991-12-23 1992-12-12 Antirheumatische naphthyridinderivate.
AU31587/93A AU656832B2 (en) 1991-12-23 1992-12-12 Anti-rheumatic naphthyridine derivatives
PCT/EP1992/002901 WO1993013097A1 (en) 1991-12-23 1992-12-12 Anti-rheumatic naphthyridine derivatives
CZ941535A CZ153594A3 (en) 1991-12-23 1992-12-12 Therapeutically active substances
CA002125858A CA2125858A1 (en) 1991-12-23 1992-12-12 Therapeutic agents
RU94030471/04A RU94030471A (ru) 1991-12-23 1992-12-12 Соединения, способ получения, фармацевтическая композиция, способ лечения ревматоидных артритов
JP5511397A JP2527917B2 (ja) 1991-12-23 1992-12-12 治療薬
EP93900052A EP0618916B1 (en) 1991-12-23 1992-12-12 Anti-rheumatic naphthyridine derivatives
SK750-94A SK75094A3 (en) 1991-12-23 1992-12-12 Naphthyridine derivatives
NZ246156A NZ246156A (en) 1991-12-23 1992-12-12 4-anilino-1,8-naphthyridine derivatives and pharmaceutical compositions
AT93900052T ATE171452T1 (de) 1991-12-23 1992-12-12 Antirheumatische naphthyridinderivate.
IN758MA1992 IN174405B (cg-RX-API-DMAC7.html) 1991-12-23 1992-12-17
IL104169A IL104169A0 (en) 1991-12-23 1992-12-18 Therapeutic agents
ZA929916A ZA929916B (en) 1991-12-23 1992-12-21 Therapeutic agents.
MX9207494A MX9207494A (es) 1991-12-23 1992-12-22 4(5)-amino-1,8-naftiridinas substituidas, procedimiento para su preparacion y composiciones farmaceuticas que las contienen.
HR921455A HRP921455A2 (en) 1991-12-23 1992-12-22 Substituted 4(5)-amino-1,8-naphthyridines
SI19929200408A SI9200408A (en) 1991-12-23 1992-12-22 Substituted 4(5)-amino-1,8-naphtyridine derivatives
YU110792A YU110792A (sh) 1991-12-23 1992-12-23 Supstituisani 4(5)amino-1,8-naftiridini formule i postupak za njihovu proizvodnju
CN93109454A CN1096784A (zh) 1991-12-23 1993-06-22 含取代4(5)-氨基-1,8-二氨杂萘的治疗剂
BG98813A BG98813A (bg) 1991-12-23 1994-05-31 Терапевтични средства
FI943019A FI943019A0 (fi) 1991-12-23 1994-06-22 Terapeuttisia aineita
NO942376A NO942376L (no) 1991-12-23 1994-06-22 Terapeutiske midler

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919127252A GB9127252D0 (en) 1991-12-23 1991-12-23 Therapeutic agents
CN93109454A CN1096784A (zh) 1991-12-23 1993-06-22 含取代4(5)-氨基-1,8-二氨杂萘的治疗剂

Publications (1)

Publication Number Publication Date
GB9127252D0 true GB9127252D0 (en) 1992-02-19

Family

ID=36822317

Family Applications (1)

Application Number Title Priority Date Filing Date
GB919127252A Pending GB9127252D0 (en) 1991-12-23 1991-12-23 Therapeutic agents

Country Status (22)

Country Link
US (1) US5464781A (cg-RX-API-DMAC7.html)
EP (1) EP0618916B1 (cg-RX-API-DMAC7.html)
JP (1) JP2527917B2 (cg-RX-API-DMAC7.html)
CN (1) CN1096784A (cg-RX-API-DMAC7.html)
AT (1) ATE171452T1 (cg-RX-API-DMAC7.html)
AU (1) AU656832B2 (cg-RX-API-DMAC7.html)
BG (1) BG98813A (cg-RX-API-DMAC7.html)
CA (1) CA2125858A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ153594A3 (cg-RX-API-DMAC7.html)
DE (1) DE69227125T2 (cg-RX-API-DMAC7.html)
FI (1) FI943019A0 (cg-RX-API-DMAC7.html)
GB (1) GB9127252D0 (cg-RX-API-DMAC7.html)
HR (1) HRP921455A2 (cg-RX-API-DMAC7.html)
HU (1) HUT66971A (cg-RX-API-DMAC7.html)
IL (1) IL104169A0 (cg-RX-API-DMAC7.html)
IN (1) IN174405B (cg-RX-API-DMAC7.html)
MX (1) MX9207494A (cg-RX-API-DMAC7.html)
NO (1) NO942376L (cg-RX-API-DMAC7.html)
NZ (1) NZ246156A (cg-RX-API-DMAC7.html)
SI (1) SI9200408A (cg-RX-API-DMAC7.html)
SK (1) SK75094A3 (cg-RX-API-DMAC7.html)
WO (1) WO1993013097A1 (cg-RX-API-DMAC7.html)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9312891D0 (en) * 1993-06-22 1993-08-04 Boots Co Plc Therapeutic agents
GB9318931D0 (en) * 1993-09-14 1993-10-27 Boots Co Plc Therapeutic agents
GB9420168D0 (en) * 1994-10-06 1994-11-23 Boots Co Plc Therapeutic agents
AR004010A1 (es) 1995-10-11 1998-09-30 Glaxo Group Ltd Compuestos heterociclicos
CN1252054C (zh) * 1996-09-25 2006-04-19 曾尼卡有限公司 抑制生长因子的作用的喹啉衍生物
RS49779B (sr) 1998-01-12 2008-06-05 Glaxo Group Limited, Biciklična heteroaromatična jedinjenja kao inhibitori protein tirozin kinaze
US6166069A (en) * 1998-05-12 2000-12-26 American Home Products Corporation Phenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
US6933299B1 (en) 1999-07-09 2005-08-23 Smithkline Beecham Corporation Anilinoquinazolines as protein tyrosine kinase inhibitors
JP2003504363A (ja) 1999-07-09 2003-02-04 グラクソ グループ リミテッド プロテインチロシンキナーゼ阻害剤としてのアニリノキナゾリン類
IL151626A0 (en) 2000-04-07 2003-04-10 Astrazeneca Ab Quinazoline compounds
US6534656B2 (en) * 2001-05-31 2003-03-18 North Carolina State University Short synthesis of pyridine-based pharmaceutical intermediates
JP2003329989A (ja) * 2002-03-06 2003-11-19 Nippon Telegr & Teleph Corp <Ntt> 光送信装置
GB0230018D0 (en) 2002-12-23 2003-01-29 Syngenta Ltd Fungicides
US8309562B2 (en) * 2003-07-03 2012-11-13 Myrexis, Inc. Compounds and therapeutical use thereof
CA2531327A1 (en) 2003-07-03 2005-01-13 Myriad Genetics, Inc. Compounds and therapeutical use thereof
AP2006003619A0 (en) 2003-12-23 2006-06-30 Pfizer Novel quinoline derivatives
CA2592900A1 (en) 2005-01-03 2006-07-13 Myriad Genetics Inc. Nitrogen containing bicyclic compounds and therapeutical use thereof
US8258145B2 (en) * 2005-01-03 2012-09-04 Myrexis, Inc. Method of treating brain cancer
ATE541844T1 (de) * 2005-12-21 2012-02-15 Abbott Lab Antivirale verbindungen
WO2007076035A2 (en) * 2005-12-21 2007-07-05 Abbott Laboratories Anti-viral compounds
WO2007081517A2 (en) 2005-12-21 2007-07-19 Abbott Laboratories Anti-viral compounds
TWI392677B (zh) * 2005-12-21 2013-04-11 Abbott Lab 抗病毒化合物、其製備方法及用途
EP2345652A1 (en) 2005-12-21 2011-07-20 Abbott Laboratories Antiviral compounds
EP2094276A4 (en) 2006-12-20 2011-01-05 Abbott Lab ANTIVIRAL COMPOUNDS
CA2727103A1 (en) * 2008-07-03 2010-01-07 Merck Patent Gmbh Naphthyridinones as aurora kinase inhibitors
WO2010097410A1 (en) 2009-02-24 2010-09-02 Respiratorius Ab Novel bronchodilating diazaheteroaryls
US8853235B2 (en) * 2009-11-23 2014-10-07 Senhwa Biosciences, Inc. Polymorphs and salts of a kinase inhibitor
ES2753523T3 (es) 2010-04-02 2020-04-13 Firmenich Incorporated Modificador del sabor dulce

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4466965A (en) * 1982-07-26 1984-08-21 American Hospital Supply Corporation Phthalazine compounds, compositions and use
NO174506B (no) * 1984-10-30 1994-02-07 Usv Pharma Corp Analogifremgangsmaate ved fremstilling av terapeutisk aktive forbindelser
EP0222839A4 (en) * 1985-05-17 1988-11-09 Univ Australian ANTI-MALARIA COMPOUNDS.
JPS6368568A (ja) * 1986-09-10 1988-03-28 Otsuka Pharmaceut Factory Inc ｐ−アミノフエノ−ル誘導体
DE3644825A1 (de) * 1986-12-31 1988-07-14 Basf Ag Substituierte 1,8-naphthyridin-derivate und diese enthaltende fungizide
AU632461B2 (en) * 1987-07-22 1993-01-07 Schering Corporation Bicyclic compounds, their use as pharmaceuticals, their preparation, and intermediates useful in their preparation
GB8804443D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
US4978661A (en) * 1988-09-29 1990-12-18 Innocenzo Caruso Use of 6-halo-4-quinolone compounds and pharmaceutical compositions thereof for the preparation of a medicament for the therapeutical application in rheumatoid arthritis
GR900100380A (el) * 1989-05-20 1991-10-10 Fisons Plc Μέ?οδος παρασκευής αντι-φλεγμονωδών παραγώγων αμινοφενόλης.
AU634561B2 (en) * 1989-07-27 1993-02-25 Eli Lilly And Company Naphthyridine derivatives
JP2988739B2 (ja) * 1990-04-16 1999-12-13 協和醗酵工業株式会社 １，８−ナフチリジン−２−オン誘導体
JP3157077B2 (ja) * 1994-02-16 2001-04-16 内山工業株式会社 ベアリングシール

Also Published As

Publication number Publication date
EP0618916B1 (en) 1998-09-23
HU9401877D0 (en) 1994-09-28
HUT66971A (en) 1995-01-30
CN1096784A (zh) 1994-12-28
MX9207494A (es) 1993-07-01
HRP921455A2 (en) 1994-12-31
CA2125858A1 (en) 1993-07-08
AU3158793A (en) 1993-07-28
AU656832B2 (en) 1995-02-16
FI943019A7 (fi) 1994-06-22
ATE171452T1 (de) 1998-10-15
WO1993013097A1 (en) 1993-07-08
CZ153594A3 (en) 1995-02-15
NO942376L (no) 1994-06-22
NZ246156A (en) 1996-01-26
IL104169A0 (en) 1993-05-13
BG98813A (bg) 1995-05-31
DE69227125D1 (de) 1998-10-29
DE69227125T2 (de) 1999-02-18
IN174405B (cg-RX-API-DMAC7.html) 1994-11-26
JPH07502280A (ja) 1995-03-09
SK75094A3 (en) 1995-04-12
JP2527917B2 (ja) 1996-08-28
US5464781A (en) 1995-11-07
SI9200408A (en) 1993-09-30
FI943019A0 (fi) 1994-06-22
EP0618916A1 (en) 1994-10-12
NO942376D0 (cg-RX-API-DMAC7.html) 1994-06-22

Similar Documents

Publication Publication Date Title
IL104169A0 (en) Therapeutic agents
AU4264396A (en) Cosmetic or pharmaceutical compositions containing mangiferin or derivatives thereof
AU2246292A (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
MY129425A (en) Indole derivatives useful a.o. for the treatment of osteoporosis
GR3034769T3 (en) Triazole antifungal agents.
IL112036A0 (en) Methods of increasing thrombomodulin expression
GB9305641D0 (en) Therapeutic agents
DE69720715D1 (en) Hexahydro-pyrido (4,3-b)indolderivate als antipsychotische arzneimittel
GB9127304D0 (en) Therapeutic agents
PL328530A1 (en) Derivatives of 3,4-disubstituted phenylethanolaminetetralincarboxyamide
NO933241L (no) Aminosyrer nyttige ved terapi av osteoartikulaere paavirkninger
JO1754B1 (en) Therapeutic agents
MY133438A (en) Morpholinobenzamide salts
AUPO227896A0 (en) Novel compounds and their preparation
ZA952403B (en) New 2,4-diphosphonoglutaric acid derivatives processes for their production and pharmaceutical agents containing these compounds
AU2796695A (en) Pyrrolidine derivatives for the treatment of cholecystokinine and gastrine-related disorders
JO1810B1 (en) Therapeutic agents
JO1755B1 (en) Therapeutic agents
MX9705218A (es) Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis de ginecomastia idiopatica o fisiologica.